Pflug Koory’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.26M | Sell |
52,493
-40
| -0.1% | -$1.05K | 0.5% | 52 |
|
|
2026
Q1 | $1.48M | Buy |
52,533
+98
| +0.2% | +$2.61K | 0.68% | 43 |
|
|
2025
Q4 | $1.31M | Sell |
52,435
-707
| -1% | -$17.8K | 0.61% | 44 |
|
|
2025
Q3 | $1.35M | Hold |
53,142
| – | – | 0.64% | 43 |
|
|
2025
Q2 | $1.29M | Buy |
53,142
+335
| +0.6% | +$7.81K | 0.65% | 45 |
|
|
2025
Q1 | $1.34M | Sell |
52,807
-411
| -0.8% | -$10.8K | 0.75% | 41 |
|
|
2024
Q4 | $1.41M | Sell |
53,218
-8
| -0% | -$217 | 0.71% | 43 |
|
|
2024
Q3 | $1.54M | Buy |
+53,226
| New | +$1.55M | 0.76% | 38 |
|
|
2024
Q1 | $1.54M | Buy |
55,416
+4,814
| +10% | +$134K | 0.76% | 38 |
|
|
2023
Q4 | $1.46M | Buy |
50,602
+1,342
| +3% | +$40.6K | 0.77% | 36 |
|
|
2023
Q3 | $1.63M | Sell |
49,260
-4,130
| -8% | -$146K | 0.94% | 26 |
|
|
2023
Q2 | $1.96M | Buy |
53,390
+365
| +0.7% | +$14.2K | 1% | 21 |
|
|
2023
Q1 | $2.16M | Sell |
53,025
-150
| -0.3% | -$6.48K | 1.18% | 19 |
|
|
2022
Q4 | $2.73M | Sell |
53,175
-422
| -0.8% | -$20.2K | 1.52% | 11 |
|
|
2022
Q3 | $2.35M | Sell |
53,597
-1,848
| -3% | -$89.8K | 1.43% | 14 |
|
|
2022
Q2 | $2.91M | Buy |
55,445
+110
| +0.2% | +$5.61K | 1.68% | 8 |
|
|
2022
Q1 | $2.87M | Sell |
55,335
-513
| -0.9% | -$26.6K | 1.44% | 10 |
|
|
2021
Q4 | $3.3M | Buy |
55,848
+537
| +1% | +$26.6K | 1.66% | 9 |
|
|
2021
Q3 | $2.38M | Sell |
55,311
-863
| -2% | -$38.2K | 1.3% | 13 |
|
|
2021
Q2 | $2.2M | Buy |
56,174
+1,155
| +2% | +$44.9K | 1.15% | 17 |
|
|
2021
Q1 | $1.99M | Buy |
55,019
+1,212
| +2% | +$43K | 1.1% | 21 |
|
|
2020
Q4 | $1.98M | Buy |
53,807
+1,179
| +2% | +$43.2K | 1.17% | 18 |
|
|
2020
Q3 | $1.83M | Buy |
52,628
+2,615
| +5% | +$91.7K | 1.24% | 15 |
|
|
2020
Q2 | $1.55M | Buy |
50,013
+12,379
| +33% | +$421K | 1.15% | 19 |
|
|
2020
Q1 | $1.17M | Buy |
37,634
+788
| +2% | +$26.9K | 1.04% | 27 |
|
|
2019
Q4 | $1.37M | Sell |
36,846
-105
| -0.3% | -$3.74K | 0.97% | 31 |
|
|
2019
Q3 | $1.26M | Sell |
36,951
-37
| -0.1% | -$1.34K | 0.96% | 30 |
|
|
2019
Q2 | $1.52M | Sell |
36,988
-369
| -1% | -$14.7K | 1.16% | 21 |
|
|
2019
Q1 | $1.5M | Sell |
37,357
-105
| -0.3% | -$4.21K | 1.18% | 21 |
|
|
2018
Q4 | $1.55M | Sell |
37,462
-53
| -0.1% | -$2.2K | 1.32% | 15 |
|
|
2018
Q3 | $1.57M | Sell |
37,515
-3,447
| -8% | -$133K | 1.27% | 20 |
|
|
2018
Q2 | $1.41M | Sell |
40,962
-2,492
| -6% | -$85.2K | 1.11% | 29 |
|
|
2018
Q1 | $1.46M | Sell |
43,454
-343
| -0.8% | -$11.8K | 1.21% | 23 |
|
|
2017
Q4 | $1.5M | Sell |
43,797
-274
| -0.6% | -$9.34K | 1.19% | 20 |
|
|
2017
Q3 | $1.49M | Buy |
44,071
+53
| +0.1% | +$1.7K | 1.22% | 18 |
|
|
2017
Q2 | $1.4M | Buy |
44,018
+769
| +2% | +$24.3K | 1.19% | 21 |
|
|
2017
Q1 | $1.4M | Buy |
43,249
+688
| +2% | +$21.7K | 1.23% | 17 |
|
|
2016
Q4 | $1.31K | Buy |
+42,561
| New | +$1.3M | 1.13% | 22 |
|
Other funds holding PFE
CWP
FWIA
ORIO
CNB
KC
Pflug Koory's PFE Position: Q2 2026 in Review
Pflug Koory reduced its Pfizer (PFE) stake by 0.08% in Q2 2026, selling an estimated $1.05K and leaving 52,493 shares worth $1.26M. The position accounts for 0.5% of the portfolio, ranked #52.
Pflug Koory first reported a position in PFE in Q4 2016 and has held it in 38 quarters since. The position peaked at $3.3M in Q4 2021. 617 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Pflug Koory held 52,493 shares of Pfizer worth $1.26M as of Q2 2026.
- Pflug Koory sold 40 Pfizer shares in Q2 2026, an estimated $1.05K.
- Pfizer made up 0.5% of Pflug Koory's portfolio in Q2 2026, its #52 holding.
- Pflug Koory first reported a position in Pfizer in Q4 2016 and has held it in 38 quarters since.
- Pflug Koory's Pfizer position peaked at $3.3M in Q4 2021.
- 617 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Pflug Koory's 13F filing for Q2 2026, filed 21 Jul 2026.